3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
7
Unknown
3
Not yet recruiting
3
Withdrawn
1
Recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
13
Lymphoid
9
CNS
7
Other hematologic neoplasm
6
Gastrointestinal
6
Head & Neck
4
Breast
4
Other solid neoplasm
2
Thoracic
1
Sarcoma
1
Other neoplasm
1
Myeloid
1
Gynecologic
1
Dermatologic
1
Conditions
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Precancerous Conditions
1
Neoplasms by Site
1
Neoplasms
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Interventions
Paclitaxel
79
Carboplatin
66
pembrolizumab
61
Bevacizumab
56
Cisplatin
48
Specimen Handling
29
Drug Therapy
26
Blood Specimen Collection
24
Cyclophosphamide
20
olaparib
19
Taxes
17
Magnetic Resonance Spectroscopy
16
Letrozole
16
Gemcitabine
16
Biopsy
16
liposomal doxorubicin
15
niraparib
14
fludarabine
14
Brachytherapy
14
Radiotherapy
13
abemaciclib
12
Topotecan
11
Nivolumab
11
Injections
11
Doxorubicin
11
lenvatinib
10
Fluorouracil
10
atezolizumab
9
Surveys and Questionnaires
9
Standard of Care
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Watchful Waiting
×
Gynecologic
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled